Literature DB >> 3378317

Pseudouridine is unsuitable as an endogenous renal clearance marker.

J T Bernert1, C J Bell, J Guntupalli, W H Hannon.   

Abstract

We assessed the clearance of endogenous pseudouridine in humans to evaluate the potential use of this modified nucleoside as a marker of glomerular filtration rate. Pseudouridine concentrations in serum ultrafiltrates and in the corresponding 24-h urine specimens from 19 healthy men were determined by high-performance liquid chromatography. Mean (and SD) pseudouridine concentrations in serum and urine from this group averaged 2.77 (0.34) mumol/L and 203.2 (64.8) mumol/L, respectively. The calculated clearances of the nucleoside [87.3 (24.9) mL/min, n = 19], however, averaged approximately one-third lower than the corresponding creatinine clearances in the same individuals [131.8 (28.4) mL/min]. Measurement of simultaneous clearances of [3H]pseudouridine and [14C]inulin in rats also yielded a lower pseudouridine clearance, 0.78 relative to inulin. Our results are thus consistent with a partial net reabsorption of pseudouridine in both experimental animals and in humans, indicating that this compound would not be a suitable endogenous marker for routine estimation of the glomerular filtration rate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3378317

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  From Discovery to Translation: Characterization of C-Mannosyltryptophan and Pseudouridine as Markers of Kidney Function.

Authors:  Peggy Sekula; Katja Dettmer; Franziska C Vogl; Wolfram Gronwald; Lisa Ellmann; Robert P Mohney; Kai-Uwe Eckardt; Karsten Suhre; Gabi Kastenmüller; Peter J Oefner; Anna Köttgen
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

2.  Characteristics of Normalization Methods in Quantitative Urinary Metabolomics-Implications for Epidemiological Applications and Interpretations.

Authors:  Tianqi Li; Tuulia Tynkkynen; Andrei Ihanus; Siyu Zhao; Ville-Petteri Mäkinen; Mika Ala-Korpela
Journal:  Biomolecules       Date:  2022-06-28

3.  Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study.

Authors:  Monika A Niewczas; Tammy L Sirich; Anna V Mathew; Jan Skupien; Robert P Mohney; James H Warram; Adam Smiles; Xiaoping Huang; Walker Walker; Jaeman Byun; Edward D Karoly; Elizabeth M Kensicki; Gerard T Berry; Joseph V Bonventre; Subramaniam Pennathur; Timothy W Meyer; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2014-01-15       Impact factor: 10.612

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.